We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CANO
151
DELISTED
Cano Health, Inc.
CANO
$463K 0.08%
+444
New +$464K
BKSY icon
152
BlackSky Technology
BKSY
$1.17B
$458K 0.07%
5,621
-6,569
-54% -$531K
CCXX.U
153
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
$438K 0.07%
40,740
-84,260
-67% -$967K
BLDR icon
154
Builders FirstSource
BLDR
$7.74B
$428K 0.07%
+13,125
New +$356K
CCIV.U
155
DELISTED
Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth
CCIV.U
$413K 0.07%
+41,260
New +$413K
MIR icon
156
Mirion Technologies
MIR
$3.75B
$412K 0.07%
+38,320
New +$397K
AXTA icon
157
Axalta
AXTA
$8.01B
$401K 0.07%
18,101
+3,970
+28% +$92K
LAZR
158
DELISTED
Luminar Technologies
LAZR
$400K 0.07%
2,333
-4,947
-68% -$833K
ESSCU
159
DELISTED
East Stone Acquisition Corporation Unit
ESSCU
$393K 0.06%
38,546
-16,454
-30% -$168K
IONS icon
160
Ionis Pharmaceuticals
IONS
$9.46B
$382K 0.06%
8,061
-13,733
-63% -$763K
AAL icon
161
PUT
American Airlines Group
AAL
$9.93B
$380K 0.06%
212,800
+61,700
+41% +$773K
MESO
162
CALL
Mesoblast
MESO
$2.16B
$365K 0.06%
+50,000
New +$1.57M
JSPR icon
163
Jasper Therapeutics
JSPR
$26.6M
$347K 0.06%
+3,500
New +$350K
NBL
164
DELISTED
Noble Energy, Inc.
NBL
$347K 0.06%
+40,592
New +$397K
AAL icon
165
American Airlines Group
AAL
$9.93B
$340K 0.06%
27,633
+11,394
+70% +$143K
DISH
166
DELISTED
DISH Network Corp.
DISH
$333K 0.05%
11,465
+4,283
+60% +$141K
SCVX.U
167
DELISTED
SCVX Corp. Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and on
SCVX.U
$331K 0.05%
+30,802
New +$330K
WPF.U
168
DELISTED
Foley Trasimene Acquisition Corp.
WPF.U
$329K 0.05%
29,108
+8,108
+39% +$88.9K
CCXX.WS
169
DELISTED
Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex
CCXX.WS
$328K 0.05%
163,900
+78,883
+93% +$169K
EIDX
170
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$325K 0.05%
+6,427
New +$289K
CRON
171
Cronos Group
CRON
$1.11B
$324K 0.05%
+64,591
New +$378K
SHPW
172
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$324K 0.05%
4,090
-7,597
-65% -$604K
LGVW.U
173
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
$321K 0.05%
31,670
-567,216
-95% -$5.79M
ID
174
DELISTED
PARTS iD, Inc.
ID
$319K 0.05%
+30,721
New +$322K
MNTS icon
175
Momentus
MNTS
$88.3M
$316K 0.05%
+3
New +$373K
5 6
7
8 9

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.